GLP-1 injection sites and rotation
The short answer
Injectable GLP-1 medications are given subcutaneously — into the fat layer just under the skin, not into muscle. Three sites are approved: the abdomen, the front of the thigh, and the back of the upper arm.
All three are considered equally effective, so choose what you can reach comfortably, and rotate the exact spot each time to protect your skin. Your product’s Instructions for Use is the authority on technique for your specific pen.
The three approved sites
- Abdomen. The most commonly used, because it is easy to see and reach. Stay at least around two inches (5 cm) away from your navel.
- Front of the thigh. Use the front and outer area of the upper leg, where there is a reasonable fat layer.
- Back of the upper arm. Effective, but hard to reach yourself — this one usually needs another person.
How to rotate
Repeatedly injecting the exact same spot can cause the tissue under the skin to change — becoming lumpy, hardened, or thickened. Beyond being uncomfortable, injecting into altered tissue can affect how the medication is absorbed.
A simple, workable approach for a weekly medication:
- Move the spot every dose. Even staying within the abdomen, shift to a different area each week — think of it in quadrants and work around them.
- Keep an interval between repeats. Leave a reasonable gap before returning to a previously used spot, and space injections at least an inch or so apart.
- Keep a simple record. A note on your phone or a mark on a calendar avoids drifting back to the same favourite spot.
Where not to inject
- Skin that is bruised, tender, red, hard, or scarred.
- Areas with stretch marks, moles, or lumps.
- Tissue that already feels thickened or lumpy from previous injections.
- Within about two inches of your navel.
- Directly into muscle — these medications are designed for subcutaneous use.
- Through clothing.
Basic technique
Pen designs differ meaningfully — some require attaching a needle and priming, others are pre-assembled single-dose devices. Follow the Instructions for Use in your product’s packaging, and ask your pharmacist to demonstrate the first time. The common principles:
- Wash your hands, and let the site dry if you clean it with an alcohol swab.
- Check the medication and expiry date; do not use it if it looks discoloured or contains particles.
- Inject at the angle your device’s instructions specify.
- Hold for the full count your instructions state before withdrawing — removing early is a common cause of an incomplete dose.
- Do not rub the site afterwards. Light pressure is fine if there is a spot of blood.
Storage and disposal
- Storage. These are biologic medicines with specific refrigeration requirements and separate rules once in use. Check your product’s instructions — do not freeze.
- Never reuse or share a needle or pen, even with a family member. Sharing injection equipment risks transmitting bloodborne infection.
- Use an FDA-cleared sharps container, or a heavy-duty plastic container with a tight lid if one is not available. Never put loose needles in household rubbish or recycling. Disposal rules vary by state — your pharmacy or local health department can tell you what applies where you live.
Contact a healthcare professional if
- An injection site becomes increasingly red, warm, swollen, or painful, or leaks pus — this may indicate infection.
- You develop hard lumps or dents in the skin at sites you have used repeatedly.
- You have a rash, hives, or swelling beyond the immediate injection area.
- You are unsure whether a dose was delivered fully — ask before injecting again.
- You experience swelling of the face, lips, tongue or throat, or difficulty breathing — seek emergency care.
For how injection timing fits into your overall schedule, see GLP-1 dosing and titration. For what to expect in the days after a dose, see our side-effect overview.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: Approved subcutaneous injection sites and administration instructions per product.
- Patient drug and condition informationMedlinePlus, U.S. National Library of MedicineSupports: Patient-level guidance on subcutaneous injection technique.
- Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Guidance on safe sharps disposal.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.